[1]
B. Matuszek, M. Lenart-Lipińska, and J. Solski, “FGF-21 – can it be a promising agent in the treatmentof type 2 diabetes?”, Curr. Issues Pharm. Med. Sci., vol. 22, no. 4, pp. 167–170, Mar. 2025, Accessed: Aug. 25, 2025. [Online]. Available: https://czasopisma.umlub.pl/curipms/article/view/2837